Cara TherapeuticsTVRD
13F holders, Q4 2024 (December 31)1holders −69
0new positions
31sold out
$0.35avg. 13F price*
At the end of Q4 2024, 1 institutions reported holding Cara Therapeutics Inc. (TVRD) in their 13F filings, down 69 from Q3 2024. 0 opened new positions and 31 sold out. The largest holder was Rathbones Group PLC ($7K).
- Company
- Cara Therapeutics Inc.
- CUSIP
- 140755109
- Latest filing quarter
- Q4 2024
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 31 | $1.3M |
All 13F filers, Q3 2024 → Q4 2024: 4,243,707 shares sold, net −4,243,707 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Rathbones Group PLC | 0.00% | No change | 20,164 | $7K |
"% of holder's portfolio" is TVRD's weight in each manager's 13F, not the share of Cara Therapeutics Inc. the manager owns.